Dr. Horn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Road
Gainesville, FL 32610Fax+1 352-294-8091
Education & Training
- University of California (San Francisco)Fellowship, Neuro-Oncology, 1997 - 1998
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1991 - 1994
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1988 - 1991
- University of Zagreb Faculty of MedicineClass of 1983
Certifications & Licensure
- FL State Medical License 2016 - 2026
- CA State Medical License 1995 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Exceptional Physician Award UCSF, 2016
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer Start of enrollment: 2003 Jan 01
- A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies Start of enrollment: 2009 Oct 01
- Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation Start of enrollment: 2018 Jun 15
Publications & Presentations
PubMed
- 64 citationsPopulation pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: A model-based dosing algorithm for personalized...Janel Long-Boyle, Rada M. Savic, Shirley Yan, Imke H. Bartelink, Lisa Musick
Therapeutic Drug Monitoring. 2015-04-01 - 39 citationsBusulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host d...Jason Law, Morton J. Cowan, Christopher C. Dvorak, Lisa Musick, Janel Long-Boyle
Biology of Blood and Marrow Transplantation. 2012-11-01 - 58 citationsAutoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.Biljana Horn, M Viele, William C. Mentzer, N Mogck, Kenneth B. DeSantes
Bone Marrow Transplantation. 1999-11-01
Press Mentions
- A Miss for Steroid-Toting Red Blood Cells in Ataxia TelangiectasiaAugust 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: